Institut Claudius Regaud
In research, Institut Claudius Regaud stands highest in Medicine (#5,442 of 10,443 worldwide) and Health Sciences (#7,181 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology — Oncology is 14.5× its share of world research.
- World rank, 2022–2025
- #15,525 of 28,054 · #10,923 all time
- Rank in France
- #664 of 1,422
- Research works
- 1.2k ◆ 2% vs 2013–17
- Citations
- 29k 25.0 per fractional work
- Top-10% rate
- 13.4% record average 16.5%
- Open access
- 23% world 28%
What is Institut Claudius Regaud known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #5,442 of 10,443 | 14.3% | 115 | #3736 | |
| Health SciencesDomain | #7,181 of 11,982 | 13.8% | 121 | #5058 |
Each strip is that field’s whole ranked pool, with the notch where Institut Claudius Regaud sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institut Claudius Regaud specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.5× the share of its output that it takes of world research.
- OncologySubfield · 24.8 works14×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Immunology and Microbiology 2.2×
- Pharmacology, Toxicology and Pharmaceutics 1.9×
- Biochemistry, Genetics and Molecular Biology 1.9×
- Dentistry 1.4×
- Health Professions 1.3×
- Mathematics 0.7×
- Physics and Astronomy 0.7×
- Economics, Econometrics and Finance 0.4×
- Neuroscience 0.4×
- Psychology 0.2×
- Chemistry 0.2×
- Decision Sciences 0.1×
- Environmental Science 0.1×
- Social Sciences 0.1×
- Chemical Engineering 0.1×
- Engineering 0.1×
- Computer Science 0.0×
- Agricultural and Biological Sciences 0.0×
- Materials Science 0.0×
- Business, Management and Accounting 0.0×
Who are the top researchers at Institut Claudius Regaud?
Ranked on the composite score, Christine Chevreau, Henri Roché and R. Bugat lead among researchers whose main affiliation is Institut Claudius Regaud.
- 1 Christine Chevreau France · #43,522 worldwide 397 citations · 64 works
- 2 Henri Roché France · #51,502 worldwide 337 citations · 45 works
- 3 R. Bugat France · #52,990 worldwide 255 citations · 48 works
- 4 Florence Dalenc France · #115,943 worldwide 315 citations · 72 works
- 5 Laurence Gladieff France · #176,194 worldwide 148 citations · 70 works
- 6 Alejandra Martínez France · #247,027 worldwide 111 citations · 84 works
- 7 Denis Querleu France · #266,294 worldwide 152 citations · 107 works
- 8 Jean‐Pierre Delord France · #273,862 worldwide 210 citations · 67 works
- 9 Magali Lacroix‐Triki France · #293,558 worldwide 86 citations · 32 works
- 10 Thomas Filleron France · #327,003 worldwide 186 citations · 69 works
Which keywords describe research at Institut Claudius Regaud?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Clinical Trials, Radiotherapy, Immunotherapy, Biomarkers, Metastasis and Survival Analysis.
- Genomic Profiling
- Endometrial Carcinoma
- Chemoradiotherapy
- Robotic Surgery
- Cetuximab
- Management
- Cervical Cancer
- Metastatic Breast Cancer
- Precision Medicine
- Molecular Subtypes
- Mutation Analysis
- Genomic Analysis
- Neoadjuvant Therapy
- Ovarian Cancer
- Cytoreductive Surgery
- Quality of Life
- Metastasis
- Epidemiology
- Radiotherapy
- Clinical Practice Guidelines
- Chemotherapy
- Clinical Trials
- Immunotherapy
- Biomarkers
- Survival Analysis
- Prognostic Factors
- Breast Cancer
- Targeted Therapy
- Tumor Microenvironment
- Molecular Classification
- Tumor Models
- Cancer
- Genetic Mutations
- Molecular Characterization
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Radiation Therapy
- Sentinel Lymph Node Biopsy
- Brachytherapy
- Prognostic Markers
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy28▲ 26×21 topics
- Clinical Practice Guidelines13▲ 16×9 topics
- Clinical Trials13▲ 13×9 topics
- Radiotherapy12▲ 21×12 topics
- Immunotherapy12▲ 11×14 topics
- Epidemiology11▲ 1.88×35 topics
- Biomarkers11▲ 11×10 topics
- Metastasis11▲ 21×10 topics
- Survival Analysis10▲ 25×7 topics
- Quality of Life10▲ 4.7×19 topics
- Prognostic Factors10▲ 15×14 topics
- Cytoreductive Surgery8▲ 84×2 topics
- Breast Cancer8▲ 23×11 topics
- Ovarian Cancer8▲ 60×3 topics
- Targeted Therapy8▲ 23×5 topics
- Neoadjuvant Therapy8▲ 22×5 topics
- Tumor Microenvironment8▲ 11×7 topics
- Genomic Analysis7▲ 19×3 topics
- Molecular Classification7▲ 31×4 topics
- Mutation Analysis7▲ 60×1 topic
- Tumor Models7▲ 76×1 topic
- Molecular Subtypes6▲ 51×3 topics
- Cancer6▲ 3.1×23 topics
- Precision Medicine6▲ 8.9×5 topics
- Genetic Mutations6▲ 9.3×11 topics
- Metastatic Breast Cancer5▲ 60×2 topics
- Molecular Characterization5▲ 19×4 topics
- Cervical Cancer5▲ 31×3 topics
- Immune Checkpoint Blockade5▲ 30×1 topic
- Management5▲ 4.2×11 topics
- PD-1 and PD-L15▲ 30×1 topic
- Cetuximab5▲ 39×2 topics
- Radiation Therapy5▲ 24×5 topics
- Robotic Surgery4▲ 20×5 topics
- Sentinel Lymph Node Biopsy4▲ 35×2 topics
- Chemoradiotherapy4▲ 53×2 topics
- Brachytherapy4▲ 66×1 topic
- Endometrial Carcinoma4▲ 66×1 topic
- Prognostic Markers4▲ 23×3 topics
- Genomic Profiling4▲ 23×2 topics
Which research topics does Institut Claudius Regaud publish most on?
By volume in 2022–2025: Ovarian cancer diagnosis and treatment, Cancer Immunotherapy and Biomarkers, Endometrial and Cervical Cancer Treatments and Breast Cancer Treatment Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ovarian cancer diagnosis and treatment Reproductive Medicine 7 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 5 works
- 3 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 4 works
- 4 Breast Cancer Treatment Studies Cancer Research 3 works
- 5 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 3 works
- 6 Colorectal Cancer Treatments and Studies Oncology 3 works
- 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works
- 8 Sarcoma Diagnosis and Treatment Pulmonary and Respiratory Medicine 2 works
- 9 Cancer Treatment and Pharmacology Oncology 2 works
- 10 Uterine Myomas and Treatments Obstetrics and Gynecology 2 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut Claudius Regaud's research output changed?
Output in 2018–2022 was 2% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Toulouse
- Université Toulouse III - Paul Sabatier
- Université Fédérale de Toulouse Midi-Pyrénées
- Université Toulouse - Jean Jaurès
- Institut National Polytechnique de Toulouse
- Université Toulouse-I-Capitole
- Hôpital Rangueil
- Laboratoire d'Analyse et d'Architecture des Systèmes
- Hôpital Purpan
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.